Blue Cross in-house development capabilities have contributed immensely to its growing product range and technology development. Blue Cross is recognized as the pioneers in Dispersible Tablets & also developed Mouth-dissolving Tablets which is convenient for the patients who have difficulty in swallowing.
Technically qualified and trained scientists with appropriate exposure is engaged in Formulation, analytical and packaging development. The development team plays a key role in supporting commercial scale-up batches including process validation programs.
R&D capabilities are utilized for the development of Novel Drug Delivery Systems (NDDS), Novel Topical drug delivery i.e. effectiveness of the drug by localization at the site of action (emulgel), target drug delivery system etc.